Marshman Fund Trust II
SEC CIK 1821461 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences Holdings, Inc. | 10% | 6.65M | — | $139.38M | 1 | 2024-11-01 | 2024-11-01 |
Most active insiders at HRMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Budur Kumar | Chief MEDICAL Off | — | $3.11M |
| 2 | Kapadia Sandip | CFO | — | $1.80M |
| 3 | Dayno Jeffrey M. | Pres, CEO, Dir | — | $1.04M |
| 4 | Zaeske Adam H. | Chief COMMERCIAL Off | — | — |
| 5 | Serafin Andrew | Chief STRATEGY Off | — | — |
Marshman Fund Trust II made no open-market trades at HRMY in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-05 | 2024-11-01+ | HRMY | Harmony Biosciences Holdings, Inc. | Marshman Fund Trust II | 10% | S - Sale | $30.30 | -4.60M | 6.65M | -41% | -$139.38M |
Purchase Sale Sale after option exercise All abbreviations